Pharmacogenomics can improve antipsychotic treatment in schizophrenia
Qingqing Xu(Ocean University of China), Shengying Qin(Shanghai Jiao Tong University), Qinghe Xing(Fudan University), Xi Wu(Chinese Academy of Sciences), Lin He(Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine), Yuyu Xiong(Henan University of Technology)
Cited by 30
Related Papers
Cytochrome P450 Enzymes and Drug Metabolism in Humans
|International Journal of Molecular Sciences|2021|939
Comparative genetic architectures of schizophrenia in East Asian and European populations
|Nature Genetics|2019|709
Sclerostin Mediates Bone Response to Mechanical Unloading Through Antagonizing Wnt/β-Catenin Signaling
|Journal of Bone and Mineral Research|2009|623
Mutations in <i>TUBB8</i> and Human Oocyte Meiotic Arrest
|New England Journal of Medicine|2016|324
Multi-faceted epigenetic dysregulation of gene expression promotes esophageal squamous cell carcinoma
|Nature Communications|2020|161